tiprankstipranks
AbbVie and Xilio Therapeutics announce collaboration
PremiumThe FlyAbbVie and Xilio Therapeutics announce collaboration
8d ago
CollPlant grants AbbVie exclusive rhCollagen technology license
Premium
The Fly
CollPlant grants AbbVie exclusive rhCollagen technology license
8d ago
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
Premium
The Fly
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
12d ago
AbbVie price target raised to $214 from $212 at Guggenheim
PremiumThe FlyAbbVie price target raised to $214 from $212 at Guggenheim
17d ago
AbbVie price target raised to $215 from $205 at Citi
Premium
The Fly
AbbVie price target raised to $215 from $205 at Citi
17d ago
AbbVie Reports Strong 2024 Growth Amid Challenges
Premium
Company Announcements
AbbVie Reports Strong 2024 Growth Amid Challenges
18d ago
AbbVie rises 7.4%
PremiumThe FlyAbbVie rises 7.4%
20d ago
Unusually active option classes on open January 31st
Premium
The Fly
Unusually active option classes on open January 31st
20d ago
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
Premium
The Fly
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100